Enamine expands collaboration with Actelion Pharmaceuticals

Enamine Ltd. has announced that it has agreed to expand its collaboration in early drug discovery with Actelion Pharmaceuticals, covering therapeutic areas including cardiovascular and central nervous system disorders, immunology, infectious diseases and oncology.
Read press release


Contact us

I have read and agree with Privacy Policy of Enamine

Send me details